Actively Recruiting

Phase Not Applicable
Age: 18Years - 79Years
All Genders
NCT04707885

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Led by Ohio State University · Updated on 2025-09-12

40

Participants Needed

5

Research Sites

320 weeks

Total Duration

On this page

Sponsors

O

Ohio State University

Lead Sponsor

N

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).

CONDITIONS

Official Title

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Who Can Participate

Age: 18Years - 79Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent form.
  • Adults aged 18 to 79 with bilateral sensorineural hearing loss that began after language development.
  • At least 30 days of experience with properly fitted binaural hearing aids verified by real ear measurements.
  • Limited benefit from conventional hearing aids with specific speech test scores in the ear to be implanted and the opposite ear.
  • Low frequency hearing thresholds (125, 250, 500 Hz) of 55 dB HL or better in the ear to be implanted.
  • Severe to profound mid to high-frequency hearing loss (1000 to 4000 Hz) of 75 dB HL or worse in the ear to be implanted.
  • Low frequency hearing thresholds of 55 dB HL or better with moderately severe to profound mid-to-high frequency hearing loss in the opposite ear.
  • Proficient in English.
  • Scheduled for implantation with a current generation cochlear implant device from Cochlear Limited or Advanced Bionics AG.
  • Willing and able to complete all testing and study visits.
Not Eligible

You will not qualify if you...

  • Previous cochlear implant surgery.
  • Hearing loss that started before language development.
  • Abnormal inner ear anatomy seen on CT imaging.
  • Auditory neuropathy spectrum disorder.
  • Retrocochlear problems such as vestibular schwannoma or stroke.
  • Unable or unwilling to comply with study procedures including randomization.
  • Medical or social barriers preventing study completion.
  • Medical conditions that contraindicate surgery.
  • Use of Med El cochlear implant device by patient choice.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

2

Washington University in St. Louis

St Louis, Missouri, United States, 63110

Actively Recruiting

3

University of North Carolina, Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

4

Ohio State University Eye and Ear Institute

Columbus, Ohio, United States, 43210

Actively Recruiting

5

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Actively Recruiting

Loading map...

Research Team

B

Beth Miles-Markley

CONTACT

M

Meghan Hiss, AuD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here